Everybody knows that is why patent applications are lodged and a priority date is set. No other company can apply for a similar patent after that date.
My point was that if ANP had exclusivity on ATL1102, why would they need to care about beating another pharma company in the new treatment patent race.
ANP Price at posting:
6.6¢ Sentiment: Hold Disclosure: Held
